Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Sanofi-Aventis New Zealand Limited,"Inactivated quadrivalent influenza vaccine, split virion (high dose)","Given the indication will be for 60 plus, it is proposed to replace SD on the Schedule, for people aged 60 plus who meet the criteria","Inactivated quadrivalent influenza vaccine, split virion (high dose) (Fluzone High-Dose Quadrivalent)",,Community and Hospital,
